CORRECTION OF RETINAL ANGIOPATHY OF HYPERTENSIVE TYPE BY DIMETHYLAMINOETHANOL DERIVATIVE 19-16 IN EXPERIMENT
Introduction: 63% of hypertensive patients have evidence of hypertensive angiopathy. Increase of effectiveness of drug therapy of retinal angiopathy of hypertensive type is an important task of pharmacology. Objectives: To increase the effectiveness of pharmacological correction of retinal angiopat...
Main Author: | Anna Peresypkina |
---|---|
Format: | Article |
Language: | English |
Published: |
Belgorod National Research University
2017-12-01
|
Series: | Research Results in Pharmacology |
Subjects: | |
Online Access: | https://rrpharmacology.pensoft.net/article/31123/download/pdf/ |
Similar Items
-
CORRECTION OF RETINAL ANGIOPATHY OF HYPERTENSIVE TYPE BY MINOXIDIL, SILDENAFIL IN EXPERIMENT
by: Anna Peresypkina, et al.
Published: (2016-12-01) -
CORRECTION OF EXPERIMENTAL RETINAL ANGIOPATHY OF HYPERTENSIVE TYPE BY MINOXIDIL, SILDENAFIL
by: A. A. PERESYPKINA, et al.
Published: (2017-05-01) -
CORRECTION OF HYPERTENSIVE NEURORETINOPATHY BY DIMETHYLAMINOETHANOL DERIVATIVE 7-16 IN EXPERIMENT
by: A. A. PERESYPKINA, et al.
Published: (2018-02-01) -
Retinal vessels caliber assessment in patients with arterial hypertension
by: N. S. Semenova, et al.
Published: (2014-07-01) -
Monitoring the Patient with Retinal Angiopathy Associated with Hereditary Transthyretin Amyloidosis: Current Perspectives
by: Marques JH, et al.
Published: (2022-07-01)